Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).
The NLCSP – Incidental Chest Findings – What Now? – A Focus on Interstitial Lung Abnormalities
Dementia & Chronic Disease – Practical Advice
Head and Neck Lumps
Why are LAMAs Useful in Asthma Management
expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis